MFSD2A and non-small cell lung carcinoma: The mechanisms underlying the inhibition of MFSD2A expression are unclear, although our preliminary experiments indicating restoration of MFSD2A expression in NSCLC cell lines upon treatment with 5'-azacytidine, a methyltransferase inhibitor and demethylating agent, suggest a role for methylation.